Latency to paroxetine-induced anxiolysis in the rat is reduced by co-administration of the 5-HT1A receptor antagonist WAY100635.

Autor: Duxon, M S, Starr, K R, Upton, N

Publikováno v: British Journal of Pharmacology; Aug2000, Vol. 130 Issue 7, p1713-1719, 7p

Evidence for accelerated desensitisation of 5-HT2C receptors following combined treatment with fluoxetine and the 5-HT1A receptor antagonist, WAY 100,635, in the rat

Autor: Bristow, L. J., O'Connor, D., Watts, R., Duxon, M. S., Hutson, P. H.

Publikováno v: Neuropharmacology; 2000, Vol. 39 Issue: 7 p1222-1236, 15p

Social threat and novel cage stress-induced sustained extracellular-regulated kinase1/2 (ERK1/2) phosphorylation but differential modulation of brain-derived neurotrophic factor (BDNF) expression in the hippocampus of NMRI mice.

Autor: Pardon MC; University of Nottingham Medical School, Institute of Neuroscience, School of Biomedical Sciences, Queen's Medical Centre, Nottingham, NG9 2UH, UK. marie.pardon@nottingham.ac.uk, Roberts RE, Marsden CA, Bianchi M, Latif ML, Duxon MS, Kendall DA

Publikováno v: Neuroscience [Neuroscience] 2005; Vol. 132 (3), pp. 561-74.

Evidence implicating a role for orexin-1 receptor modulation of paradoxical sleep in the rat.

Autor: Smith MI; Neurology-CEDD, GlaxoSmithkline, New Frontiers Science Park North, Third Avenue, Harlow, Essex, UK, CM19 5AW. martin_i_smith@gsk.com, Piper DC, Duxon MS, Upton N

Publikováno v: Neuroscience letters [Neurosci Lett] 2003 May 08; Vol. 341 (3), pp. 256-8.

Effect of SB-243213, a selective 5-HT(2C) receptor antagonist, on the rat sleep profile: a comparison to paroxetine.

Autor: Smith MI; Neurology-CEDD, GlaxoSmithKline, New Frontiers Science Park North, Third Avenue, Essex CM19 5AW, Harlow, UK. martin_i_smith@gsk.com, Piper DC, Duxon MS, Upton N

Publikováno v: Pharmacology, biochemistry, and behavior [Pharmacol Biochem Behav] 2002 Apr; Vol. 71 (4), pp. 599-605.